达丁类药物诱导的免疫媒介性死性肌肉病变:一种罕见且未被认可的渐进性衰弱原因的病例报告
Shivendra Tangutoori1, Sai Subramanyam Kommineni1, Dedeepya Gullapalli2
1Internal Medicine, Appalachian Regional Healthcare, Harlan, USA.
Cureus
|December 12, 2025
概括
达丁类药物诱导的死性自身免疫性肌肉病变会导致肌肉衰弱和亡. 早期诊断和免疫抑制疗法,如IVIg,对于恢复肌肉力量至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 类风湿病学 类风湿病学
背景情况:
- 类他类药物诱导的死性自身免疫肌肉病变 (SINAM) 是一种罕见的免疫媒介疾病.
- 在使用他类药物后,它呈现为近端肌肉软弱和肌酸激酶水平升高.
研究的目的:
- 报告一个SINAM病例.
- 突出这种罕见肌肉病的诊断和管理策略.
主要方法:
- 54岁的病人临床表现,近端肌肉疲弱.
- 实验室检测包括抗HMGCR自身抗体.
- 肌肉活组织检查结果显示,死与最小的炎症.
主要成果:
- 患者的抗HMGCR自身抗体检测结果呈阳性.
- 肌肉活检证实了死性肌肉病变.
- 静脉注射免疫球蛋白的治疗导致了良好的临床反应.
结论:
- 早期识别他类药物诱导的肌肉病变至关重要.
- 诊断可以在临床上通过阳性自身抗体进行,但活检对非典型病例有价值.
- 及时的免疫抑制疗法可以改善肌肉功能.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Myasthenia Gravis: Diagnostic Tests
1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Disorders of the Skeletal Muscle
1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
Myocarditis I: Introduction
328
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
328
Chemical Synapses
11.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.1K


